Narrow Therapeutic Index Drugs: Definition, Classic Examples, and Monitoring Imperatives

Narrow Therapeutic Index Drugs (NTIDs) — also called narrow therapeutic window drugs — have a minimal margin between the minimum effective concentration (MEC) and minimum toxic concentration (MTC) in blood. Small dose or clearance changes can swing a patient from therapeutic benefit to toxicity or therapeutic failure.

Regulatory Definition (FDA)

An NTID meets either criterion:

  • Ratio of median lethal dose (LD₅₀) to median effective dose (ED₅₀) < 2 (in animals), OR
  • Ratio of minimum toxic concentration to minimum effective concentration in humans < 2, AND
  • Therapeutic failure or toxicity from small dosage changes has serious clinical consequences

Classic NTIDs (Well-Defined Therapeutic Windows)

Drug Therapeutic Range Toxicity Threshold Monitoring
WarfarinINR 2.0–3.0 (most)INR >4.0 (bleeding)INR q1–4wk
Phenytoin10–20 µg/mL (total)>20 µg/mL (nystagmus, ataxia, coma)Trough levels; free fraction if hypoalbuminemia
Digoxin0.5–0.9 ng/mL (HF); 0.8–2.0 (AF)>2.0 ng/mL (arrhythmias, GI, visual)Trough (6–8h post-dose); renal function, K⁺, Mg²⁺
Theophylline10–20 µg/mL>20 µg/mL (seizures, arrhythmias)Trough levels
Carbamazepine4–12 µg/mL>12 µg/mL (ataxia, diplopia, hyponatremia)Trough; CBC, LFTs, Na⁺
Valproic acid50–100 µg/mL>100 µg/mL (hepatotoxicity, thrombocytopenia)Trough; LFTs, platelets, ammonia
Lithium0.6–1.0 mmol/L (maintenance)>1.5 mmol/L (severe neurotoxicity)Trough (12h post-dose); q3mo stable; renal, thyroid

Concentration-Dependent Toxicity Drugs (No Fixed Window)

These require therapeutic drug monitoring (TDM) but lack a universally accepted therapeutic range:

  • Aminoglycosides (gentamicin, tobramycin, amikacin): Extended-interval dosing; monitor peak/trough or AUC; nephrotoxicity, ototoxicity
  • Vancomycin: AUC/MIC-guided (400–600 mg·h/L); trough 15–20 for serious MRSA; nephrotoxicity
  • Cyclosporine / Tacrolimus: Whole blood trough (C₀) or C₂; nephrotoxicity, neurotoxicity, rejection balance
  • Sirolimus / Everolimus: Trough monitoring; hyperlipidemia, thrombocytopenia, wound healing

Clinical Imperatives for NTIDs

  1. Therapeutic Drug Monitoring (TDM): Timing standardized (trough vs. peak vs. AUC); lab method consistent
  2. Individualized dosing: Weight, age, renal/hepatic function, genetics (CYP2C9/VKORC1 for warfarin), interactions
  3. Interaction vigilance: Enzyme induction/inhibition, displacement, renal clearance competition
  4. Patient education: Adherence, OTC/herbal risks, illness (dehydration → ↑ levels), pregnancy
  5. Transition of care: Clear communication of levels, dose, monitoring plan at handoffs

NTIDs exemplify precision medicine before the term existed: the right dose for the right patient at the right time, verified by measurement.

Prescription Medications - Related Articles